首页> 美国卫生研究院文献>Journal of Negative Results in Biomedicine >Multiple dosing strategies with acetyl L-carnitine (ALCAR) fail to alter age-related hearing loss in the Fischer 344/NHsd rat
【2h】

Multiple dosing strategies with acetyl L-carnitine (ALCAR) fail to alter age-related hearing loss in the Fischer 344/NHsd rat

机译:乙酰左旋肉碱(ALCAR)的多种给药策略无法改变Fischer 344 / NHsd大鼠与年龄有关的听力损失

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

BackgroundThe Fischer 344/NHsd rat undergoes age-related, progressive, high-frequency hearing loss beginning at age 12 months. The loss has been linked to defects/death in the outer hair cells related to oxidative stress originating in the mitochondria. Acetyl L-carnitine (ALCAR) is known to enhance mitochondrial bioenergetics and membrane efficiency. Therefore, ALCAR was targeted as a possible pharmacologic intervention to prevent, or even restore, hearing loss from aging.
机译:背景Fischer 344 / NHsd大鼠从12个月大时开始经历与年龄相关的进行性高频听力损失。该损失与外部线粒细胞中与源自线粒体的氧化应激有关的缺陷/死亡有关。乙酰基L-肉碱(ALCAR)可以增强线粒体的生物能和膜效率。因此,ALCAR的目标是作为预防或什至恢复因衰老而引起的听力损失的可能的药物干预措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号